|
Recent developments is healthcare, technology, science and business point to the inevitable convergence of genomics with healthcare and clinical information systems. The ever increasing costs and risks associated with the approval process make better selection of subjects and other improvements in adaptive clinical trials vital. The significant growth in healthcare costs and world-wide budgetary pressures make wider adoption of outcome-based pricing models extremely likely. Fortunately, rapid advances in genomic science and data generation technologies make personalized medicine a distinct and profitable possibility in not too distant future.? Taking advantage of personal diagnostics and classification methods requires effective integration of genomic data and analytics with clinical and healthcare system
|
Date |
Mon, June 21, 2010, 16:00-17:00
（Networking 17:00〜18:00） |
Place |
Japan Bioindustry Association Seminar Room→〔MAP〕
Grande Bldg. 8F, 2-26-9 Hatchobori, Chuo-ku, Tokyo 104-0032, JAPAN
Access:
・Tokyo Metro Hibiya Line Hatchobori Station : 1 minutes walk from Exit A4
・JR Keiyo lines Hatchobori Station : 4 minutes walk from Exit B1
|
Organaizer |
Japan Bioindustry Association
|
Speaker |
Dr. Boris Umylny of Chair of the Bioscience Subcommittee in the American Chamber of Commerce in Japan & president of Japan Bioinformatics KK
Profile:
Dr. Umylny has an undergraduate degree in Computer Science from Columbia University, PhD in Cell and Molecular Biology from University of Hawaii and over 20 years professional experience. He first came to Japan in 1992 when he co-founded Fusion Systems Japan, a Tokyo-based consulting and software development company specializing in financial systems development. He served as Vice President of the Company from 1992 until selling the firm in an M&A transaction in 1999. In 2001 he enrolled in a PhD program at University of Hawaii, he received his degree in December of 2006.? He founded Japan Bioinformatics KK in December 2007. Dr. Umylny also serves as chair of the Bioscience Subcommittee in the American Chamber of Commerce in Japan.
Publications:
Umylny B., Presting G., Ward WS, "Evidence of Alu and B1 expression in dbEST", Arch Androl. 2007 Jul-Aug;53(4):207-18.
Umylny B, Presting G, Efird JT, Klimovitsky B, Ward WS, "Most human Alu and murine B1 repeats are unique", J Cell Biochem. 2007 Sep 1;102(1):110-21.
|
| 【 Program 】 |
16:00〜17:00 |
"Management and Analysis of Genomic Data in Clinical Trials and Healthcare Information Systems "
|
17:00〜18:00 |
Networking
|
Fee |
Seminar participation fees：JBAmember：Free nonmember：\1,000
Networking participation fees：All participants：\1,000
|
|
Registration |
Please register via e-mail at jbi2010@jba.or.jp before June 16th.
（required field: Corporate Name, Department, Name, E-mail Address, Networking participation）
※Space is limited, so please register early.
|
Contact |
Japan Bioindustry Association Secretariat Tanaka, and Aoki
Grande Bldg. 8F, 2-26-9 Hatchobori, Chuo-ku, Tokyo 104-0032, JAPAN
Phone: +81-3-5541-2731 Fax: +81-3-5541-2737
E-mail: jbi2010@jba.or.jp
|
|
